CLINICAL TRIAL SUPPLY CHAIN OPTIMIZATION
Day 1: 22nd September 2026
Integrating Operations, Digital Innovation, AI-Driven Forecasting, and Strategic Partnerships for Resilient, Patient-Centric, and Globally Compliant Trial Delivery
INTERACTIVE PANEL DISCUSSION
09:00 Optimizing End-to-End Clinical Trial Supply Chains in a Decentralized Trial Environment
This panel explores how decentralized and hybrid clinical trial models are reshaping supply chain strategies, emphasizing the need to manage global logistics complexity, ensure temperature-controlled distribution for sensitive therapies, and leverage digital platforms for real-time visibility. It also highlights solutions for last-mile delivery to remote patients, improved integration between clinical and supply chain teams, and balancing cost efficiency with regulatory compliance and patient-centric approaches.
Discussion Topics:
Managing logistics complexity introduced by decentralized and hybrid clinical trial models across regions
Ensuring temperature-controlled distribution for biologics and advanced therapy medicinal products globally
Leveraging digital platforms for real-time supply chain visibility and proactive risk mitigation
Addressing last-mile delivery challenges to patients participating remotely in clinical trials
Integrating clinical operations and supply chain teams for synchronized trial execution
Balancing cost efficiency while maintaining compliance and patient-centric delivery strategies
FROM SILOS TO SYNERGY
10:30 Transforming Clinical Trial Execution Through Integrated Supply Chain and Operations, Shared Data Platforms, and Cross-Functional Governance
This talk explores how integrating clinical trial supply chain planning with clinical operations can significantly improve execution and outcomes. It highlights the importance of strengthening communication between traditionally siloed teams and leveraging shared data platforms to enable synchronized planning and real-time decision-making. Attendees will learn practical approaches to reducing delays caused by misalignment between operational and supply activities, while implementing cross-functional governance structures that support faster, more informed decisions. The session also examines how to measure the impact of this integration on trial timelines, efficiency, and overall success rates, offering actionable insights for organizations aiming to modernize and streamline their clinical trial processes.
10:55 Questions & Discussion
11:00 Morning Break
INTERACTIVE PANEL DISCUSSION
11:30 Leveraging Artificial Intelligence and Predictive Analytics in Clinical Supply Chain Forecasting
This panel explores how artificial intelligence and predictive analytics are transforming clinical supply chain forecasting. Experts will discuss leveraging machine learning to enhance demand accuracy, integrating historical and real-time data for adaptive planning, minimizing waste through optimized inventory and expiry management, and accelerating decisions via automated analytics. The session also addresses data quality challenges and ensuring AI-driven outputs remain aligned with regulatory and compliance standards.
Discussion Topics:
Applying machine learning models to improve demand forecasting accuracy across clinical trial phases
Integrating historical trial data with real-time inputs for dynamic supply planning adjustments
Reducing waste through optimized inventory levels and expiry management using predictive insights
Enhancing decision-making speed through automated analytics dashboards and reporting tools
Addressing data quality challenges that impact predictive model performance and reliability
Aligning AI-driven forecasting outputs with regulatory and quality compliance requirements
13:00 Lunch Break
INTERACTIVE PANEL DISCUSSION
14:00 Vendor Management and Strategic Partnerships in Clinical Trial Supply Chain Ecosystems
This interactive panel explores best practices in vendor management and strategic partnerships within clinical trial supply chains. It highlights vendor selection based on quality, reliability, and global capability, alongside the use of performance metrics to ensure consistent outcomes. The discussion emphasizes collaborative partnerships to drive innovation, proactive risk management through audits, and aligning vendor strategies with clinical timelines to strengthen resilience and global reach.
Discussion Topics:
Selecting and qualifying vendors based on quality, reliability, and global operational capabilities
Establishing performance metrics and service level agreements to ensure consistent delivery outcomes
Building collaborative partnerships to enhance innovation and problem-solving capabilities
Managing vendor risks through regular audits and performance reviews
Aligning vendor strategies with clinical development timelines and organizational objectives
Leveraging strategic partnerships to expand global reach and improve supply chain resilience
15:30 Afternoon Break
TEMPERATURE CONTROLLED PACKAGING
16:00 Design and validation of temperature controlled packaging solutions for biologics and advanced therapy medicinal products in clinical trials
Key points
Selection criteria for passive versus active thermal packaging systems
Thermal qualification protocols under ISTA and GDP aligned conditions
Impact of biologics sensitivity on packaging design and stability requirements
Lane risk assessment including ambient profiles and transit duration variability
Lifecycle management of reusable packaging and sustainability considerations
16:25 Questions & Discussion
ADVANCED THERAPY LOGISTICS
16:30 Cold Chain Logistics Innovations for Advanced Therapies and Biologics in Clinical Trials
Addressing ultra-low temperature requirements for cell and gene therapies distribution globally
Evaluating new packaging technologies that maintain product integrity during extended transit times
Monitoring temperature excursions using IoT-enabled smart sensors and real-time alerts
Ensuring compliance with Good Distribution Practice guidelines across multiple jurisdictions
Training logistics partners on handling sensitive biologics and personalized medicine products
Balancing cost implications of advanced cold chain solutions with clinical trial budget constraints
16:55 Questions & Discussion
17:00 End of Day One

